Prev Arrow Stocks

Colgate-Palmolive Company ($CL) Stock Forecast: Up 5.1% Today

Morpher AI identified a bullish signal. The stock price may continue to rise based on the momentum of the good news.

What is Colgate-Palmolive Company?

Colgate-Palmolive (CL) is a multinational consumer goods company recognized for its products in oral care, personal care, and household categories. It has a global presence across key markets.

Why is Colgate-Palmolive Company going up?

CL stock is up 5.1% on May 1, 2026 15:10

  • Colgate-Palmolive (CL) saw a significant increase in its stock price today after posting strong Q1 results.
  • The company exceeded revenue and profit forecasts, propelled by high demand for essential household goods such as oral and personal care products in international markets.
  • Robust growth in both sales and profits in various segments, as well as a balance between volume and pricing improvements, bolstered investor confidence.
  • Despite facing challenges from rising prices and uncertain economic conditions, Colgate-Palmolive's ability to stick to its full-year goals highlighted its resilience and strategic planning efforts.

CL Price Chart

CL Technical Analysis

CL News

Colgate-Palmolive beats Q1 estimates on strong international demand

Colgate-Palmolive (CL.N) exceeded first-quarter sales and profit expectations, driven by robust international demand for essential household products like oral and personal care items. The company attributed its success to steady demand and price increases, which helped offset higher tariffs and raw material costs. Despite facing inflationary pressures and declining volumes in North America, Colgate-Palmolive reaffirmed its annual sales and profit forecasts, acknowledging persistent volatile macroeconomic conditions.

https://www.reuters.com/business/retail-consumer/colgate-palmolive-beats-q1-estimates-strong-international-demand-2026-05-01/

0 Missing News Article Image Colgate-Palmolive beats Q1 estimates on strong international demand

Colgate-Palmolive’s (NYSE:CL) Q1 CY2026 Sales Beat Estimates

Colgate-Palmolive (NYSE:CL) reported better-than-expected revenue in Q1 CY2026, with sales increasing 8.4% year-on-year to $5.32 billion, surpassing analyst estimates. The company also beat non-GAAP profit expectations, achieving $0.97 per share. This strong performance was driven by broad-based top and bottom-line growth across categories and divisions, with a balance of volume and pricing growth.

https://www.financialcontent.com/article/stockstory-2026-5-1-colgate-palmolives-nysecl-q1-cy2026-sales-beat-estimates

1 News Article Image Colgate-Palmolive’s (NYSE:CL) Q1 CY2026 Sales Beat Estimates

Colgate-Palmolive tops Q1 expectations after broad-based growth, shares gain

Colgate-Palmolive (NYSE:CL) exceeded Q1 analyst expectations with adjusted EPS of $0.97 and revenue of $5.32 billion, driven by broad-based growth across all categories and most divisions. Despite a slight decrease in gross profit margin and GAAP EPS, the company's stock rose 1.9%, and it maintained its full-year 2026 guidance for net and organic sales growth. Colgate-Palmolive also announced an expansion of its Strategic Growth and Productivity Program.

https://www.investing.com/news/earnings/colgatepalmolive-tops-q1-expectations-after-broadbased-growth-shares-gain-4652643

2 Missing News Article Image Colgate-Palmolive tops Q1 expectations after broad-based growth, shares gain

Colgate-Palmolive: Q1 Earnings Snapshot

Colgate-Palmolive Co. (CL) reported strong first-quarter earnings, with a profit of $646 million, or 80 cents per share. Adjusted earnings per share reached 97 cents, surpassing analysts' expectations of 95 cents. The company also exceeded revenue forecasts, posting $5.32 billion against an expected $5.2 billion.

https://www.10tv.com/article/syndication/associatedpress/colgate-palmolive-q1-earnings-snapshot/616-138518ae-1b61-49f2-adfd-610a53a1daad

3 News Article Image Colgate-Palmolive: Q1 Earnings Snapshot

Colgate-Palmolive Q1 net sales above forecast at $5.3B

Colgate-Palmolive announced its first-quarter net sales, totaling $5.3 billion, which exceeded forecasts. This performance indicates a stronger-than-anticipated start to the fiscal year for the consumer products giant.

https://breakingthenews.net/Article/Colgate-Palmolive-Q1-net-sales-above-forecast-at-dollar5.3B/66200644

4 News Article Image Colgate-Palmolive Q1 net sales above forecast at $5.3B

Colgate-Palmolive Company Price History

01.04.2026 - CL Stock was up 5.1%

  • Colgate-Palmolive (CL) saw a significant increase in its stock price today after posting strong Q1 results.
  • The company exceeded revenue and profit forecasts, propelled by high demand for essential household goods such as oral and personal care products in international markets.
  • Robust growth in both sales and profits in various segments, as well as a balance between volume and pricing improvements, bolstered investor confidence.
  • Despite facing challenges from rising prices and uncertain economic conditions, Colgate-Palmolive's ability to stick to its full-year goals highlighted its resilience and strategic planning efforts.

21.10.2025 - CL Stock was up 3.1%

  • Despite a slight decline in the current session, Colgate-Palmolive (CL) demonstrated a strong bullish movement overall.
  • The recent stock price decrease over the past month and year could have attracted long-term shareholders seeking a potential buying opportunity.
  • There is growing investor optimism regarding the company's future performance and growth prospects, which has resulted in increased buying pressure and pushed the stock price higher.
  • Overall, market sentiment towards Colgate-Palmolive appears positive, potentially driven by expectations of improved financial results or strategic developments within the company.

30.00.2026 - CL Stock was up 5.1%

  • Colgate-Palmolive faced a loss in the fourth quarter due to charges stemming from its skin-health business. However, the company exceeded sales expectations, primarily driven by the continuous high demand for oral care and cleaning products.
  • The company's positive outlook on annual sales, fueled by strong consumer demand for essential items, played a role in the stock's optimistic trajectory.
  • Colgate-Palmolive's success in enhancing margins through price adjustments and the favorable performance of its international sales bolstered investor confidence in its future outlook.
  • Analysts foresee similar growth rates in revenue for the coming 12 months, hinting at potential challenges in sustaining demand, a factor that investors will monitor closely.

30.00.2026 - CL Stock was up 5.0%

  • Colgate-Palmolive (CL) stock rose over 5% in a strong bullish movement recently.
  • Investors reacted positively to the company's better-than-expected organic sales growth in the fourth quarter, particularly due to a successful rebound in Latin America.
  • Despite facing a notable non-cash impairment charge linked to its skin health business, investors focused on the strength of the core business and sales growth, leading to an increase in the stock price.
  • Colgate-Palmolive's cautious outlook for 2026 includes an expected organic sales growth ranging between 1% and 4%, an increase in advertising spending, and utilizing strong operating cash flow, all of which boosted investor confidence in the company's future prospects.

08.00.2026 - CL Stock was up 5.0%

  • CL showed strong bullish movement recently.
  • Increased investor interest in CL was influenced by factors like stable product demand, cost reductions, enhanced marketing strategies, and an attractive dividend profile.
  • Analysts foresee future growth in revenue and profitability for CL, fostering positive investor sentiment.
  • An upgrade by Piper Sandler to "Overweight" and a rise in the price target added to the upbeat outlook on Colgate-Palmolive's future performance.
i
Disclaimer
Morpher is not liable for the content of the AI investment insights. Like most GPT-powered tools, these summaries may contain AI hallucinations and inaccurate information. Morpher is not presenting you with any investment advice. All investments involve risk, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. These summaries do not constitute investment advice.